Homepage
Author:
SQ Innovation
Posted Date:
May 11, 2026
Trial Results Support At-Home Treatment of Edema in Heart Failure with Subcutaneous Furosemide as an Effective and Safe Alternative to Inpatient Hospital Care
SQ Innovation
May 11, 2026
Lasix® ONYU[1] Achieves CE Marking under EU Medical Device Regulation, Reaching a Critical Milestone Toward International Market Authorization; European Medicines Agency Confirms Eligibility for Centralized Procedure Review Based on Technical Innovation
SQ Innovation
May 3, 2026
Lasix® ONYU Now Available from Walmart Specialty Pharmacy for Home Delivery
SQ Innovation
May 2, 2026
SQ Innovation and FIS Announce Strategic Supply Agreement for Furosemide API
SQ Innovation
May 1, 2026
SQ Innovation’s Lasix® ONYU Now Available for Order Through Major U.S. Pharmaceutical Distributors
SQ Innovation
February 11, 2026
